Pfizer Inc. (PFE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pfizer Inc.

    NYSE: PFE · Real-Time Price · USD
    24.57
    -0.31 (-1.25%)
    At close: Sep 08, 2025, 3:59 PM
    24.62
    0.22%
    Pre-market: Sep 09, 2025, 05:38 AM EDT

    Pfizer Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.04B 2.85B 416M 1.94B
    Short-Term Investments
    		 19.43B 9.84B 22.32B 29.13B
    Long-Term Investments
    		 2.23B 15.37B 15.07B 21.53B
    Other Long-Term Assets
    		 9.82B 12.47B 13.16B 7.68B
    Receivables
    		 14.78B 15.54B 14.53B 15.74B
    Inventory
    		 10.85B 10.19B 8.98B 9.06B
    Other Current Assets
    		 4.25B 4.91B 5.02B 3.82B
    Total Current Assets
    		 50.36B 43.33B 51.26B 59.69B
    Property-Plant & Equipment
    		 18.39B 18.94B 16.27B 14.88B
    Goodwill & Intangibles
    		 123.94B 132.68B 94.75B 74.35B
    Total Long-Term Assets
    		 163.04B 183.17B 145.94B 121.78B
    Total Assets
    		 213.4B 226.5B 197.21B 181.48B
    Account Payables
    		 5.63B 6.71B 6.81B 5.58B
    Deferred Revenue
    		 1.51B 2.7B 2.52B 3.07B
    Short-Term Debt
    		 6.95B 10.35B 2.93B 2.24B
    Other Current Liabilities
    		 23.56B 23.32B 25.98B 28.27B
    Total Current Liabilities
    		 42.99B 47.79B 42.14B 42.67B
    Long-Term Debt
    		 56.7B 60.5B 31.93B 34.76B
    Other Long-Term Liabilities
    		 23.08B 28.28B 26.2B 26.24B
    Total Long-Term Liabilities
    		 81.9B 89.42B 59.15B 61.34B
    Total Liabilities
    		 124.9B 137.21B 101.29B 104.01B
    Total Debt
    		 63.65B 70.84B 34.86B 37B
    Common Stock
    		 480M 478M 476M 473M
    Retained Earnings
    		 116.72B 118.35B 125.66B 103.39B
    Comprehensive Income
    		 -7.84B -7.96B -8.3B -5.9B
    Shareholders Equity
    		 88.2B 89.01B 95.66B 77.2B
    Total Investments
    		 21.66B 25.2B 37.38B 50.65B

    Add to Watchlist